TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Arthro Therapeutics AB
Closing information (x1000 SEK)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 |
| Turnover |
310,813
|
216,017
|
42,867 |
| Financial expenses |
13,641
|
12,059
|
10,673 |
| Earnings before taxes |
-69,801
|
-74,755
|
-130,968 |
| EBITDA |
-9,475
|
-18,575
|
-86,813 |
| Total assets |
181,367
|
191,665
|
286,683 |
| Current assets |
70,993
|
56,851
|
92,116 |
| Current liabilities |
46,227
|
68,177
|
26,499 |
| Equity capital |
-104,007
|
-104,766
|
60,692 |
| - share capital |
595
|
484
|
365 |
| Employees (average) |
191
|
157
|
85 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 |
| Solvency |
-57.3%
|
-54.7%
|
21.2% |
| Turnover per employee |
1,627
|
1,376
|
504 |
| Profit as a percentage of turnover |
-22.5%
|
-34.6%
|
-305.5% |
| Return on assets (ROA) |
-31.0%
|
-32.7%
|
-42.0% |
| Current ratio |
153.6%
|
83.4%
|
347.6% |
| Return on equity (ROE) |
67.1%
|
71.4%
|
-215.8% |
| Change turnover |
94,796
|
173,150
|
-117,609 |
| Change turnover % | 44% | -73% | |
| Chg. No. of employees |
34
|
72
|
5 |
| Chg. No. of employees % | 22% | 6% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.